TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 28010731

Group type: EXPERIMENTAL
Intervention: Designated research nurse, GCP training, trial-related training sessions for staff
Number of subjects: 508

Group type: COMPARATOR
Intervention: Heavy clinical workload, shift patterns of work, inadequate number of trained staff, time and setting of consent seeking, non-availability of research staff out of hours, parents' concerns about experimental medicine
Number of subjects: 508
Study: 24983199

Group type: EXPERIMENTAL
Intervention: Repetitive sessions of formative self-testing (RFST)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Repetitive sessions of formative self-testing with additional practice (RFSTAP)
Number of subjects: 196
Study: 23220798

Group type: EXPERIMENTAL
Intervention: 6-month exercise intervention (moderate-intensity bicycle exercise for ∼40 min, 2.5 times per week)
Number of subjects: 131
Study: 21660402

Group type: EXPERIMENTAL
Intervention: Zinc sulfate (2 mg/kg/d, maximum 20 mg in 2 divided doses, for 5 days)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study: 18434918

Group type: EXPERIMENTAL
Intervention: Methylphenidate transdermal system worn for 4 hours
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methylphenidate transdermal system worn for 6 hours
Number of subjects: 0

Group type: COMPARATOR
Intervention: Methylphenidate transdermal system (various doses: 10, 15, 20, or 30 mg) worn for 9 hours
Number of subjects: 0
Study: 16544177

Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg deoxyspergualin (DSG)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg deoxyspergualin (DSG)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Both doses of deoxyspergualin (DSG)
Number of subjects: 44
Study: 14662279

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Global assessment
Number of subjects: 401
Study: 10718390

Group type: EXPERIMENTAL
Intervention: Synergistic sedation with low-dose midazolam and propofol (group II), median dose of 2 mg midazolam and median 100 mg propofol (IQR 53 to 145) with a maximal bolus of 50 mg.
Number of subjects: 79

Group type: COMPARATOR
Intervention: Standard combination of midazolam and nalbuphine (group I), median dose of 9 mg midazolam (IQR 6 to 12) and median 20 mg nalbuphine (IQR 10 to 20).
Number of subjects: 79
Study: 9185636

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg
Number of subjects: 1049

Group type: COMPARATOR
Intervention: Lovastatin 20 mg
Number of subjects: 1049

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1049
Study: 1350366

Group type: EXPERIMENTAL
Intervention: Inhaled salmeterol (50 micrograms morning and evening)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Theophylline-ketotifen association (300 mg and 1 mg morning and evening)
Number of subjects: 96
Study: 2969912

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional insulin treatment (CIT)
Number of subjects: 24
Study: 31325107

Group type: EXPERIMENTAL
Intervention: Continuous postoperative pericardial flushing (CPPF) with 0.9% NaCl at 38 °C for up to 8 hours postoperative
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (non-CPPF)
Number of subjects: 42
Study: 29402651

Group type: EXPERIMENTAL
Intervention: Sunbeam Program (progressive resistance training plus balance exercise for 50 hours over 25 weeks)
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Sunbeam Program
Number of subjects: 221

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 221
Study: 27525532

Group type: EXPERIMENTAL
Intervention: SC administration of 20 mcg of teriparatide every 12 hours until discharge
Number of subjects: 26

Group type: COMPARATOR
Intervention: Standard clinical care
Number of subjects: 26
Study: 25335656

Group type: EXPERIMENTAL
Intervention: Motivational intervention group (study group)
Number of subjects: 696

Group type: COMPARATOR
Intervention: Routine monitoring (control group)
Number of subjects: 696
Study: 23075700

Group type: EXPERIMENTAL
Intervention: Lidcombe Program
Number of subjects: 10
Study: 20979696

Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiotherapy plus adjuvant chemotherapy
Number of subjects: 156

Group type: COMPARATOR
Intervention: Radiotherapy
Number of subjects: 156
Study: 18850461

Group type: EXPERIMENTAL
Intervention: Total laparoscopic hysterectomy (TLH)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Coagulation of uterine arteries at their origin plus total laparoscopic hysterectomy (CUA + TLH)
Number of subjects: 123
Study: 16263827

Group type: EXPERIMENTAL
Intervention: 0.5 mg melatonin
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: 3.0 mg melatonin
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 12610739

Group type: EXPERIMENTAL
Intervention: Hydrochloride salt (8 mg/kg quinine base every 8 h by slow 4-h intravenous infusion)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Cinchona alkaloid mixture (8 mg/kg quinine base every 8 h by slow 4-h intravenous infusion)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Hydrochloride salt (8 mg/kg quinine base every 8 h by intrarectal administration)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Cinchona alkaloid mixture (8 mg/kg quinine base every 8 h by intrarectal administration)
Number of subjects: 48
Study: 10353861

Group type: EXPERIMENTAL
Intervention: sc rIL-2 (3 x 10(6) IU once a day) with HAART
Number of subjects: 25

Group type: COMPARATOR
Intervention: HAART alone (control group)
Number of subjects: 25
Study: 8629065

Group type: EXPERIMENTAL
Intervention: Symptomatic therapy alone
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Symptomatic therapy plus antibiotics
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Symptomatic therapy followed by diethylcarbamazine citrate (DEC)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Symptomatic therapy plus antibiotics followed by DEC
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Hygienic measures combined with good foot care and local antibiotic/antifungal cream application
Number of subjects: 65
Study: 1792369

Group type: EXPERIMENTAL
Intervention: nisoldipine
Number of subjects: 50

Group type: COMPARATOR
Intervention: alpha-methyldopa
Number of subjects: 50
Study: 6999399

Group type: EXPERIMENTAL
Intervention: Additional high‐voltage irradiation to the pelvic field (4000 rads to the pelvic lymph nodes)
Number of subjects: 540

Group type: COMPARATOR
Intervention: No further treatment (controls)
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Patients with vessel invasion
Number of subjects: 540
Study: 29081179

Group type: EXPERIMENTAL
Intervention: ILK-CSC injection (1×10^5 cells/30 μl)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Ad-null-CSC injection (1×10^5 cells/30 μl)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saline injection
Number of subjects: 40
Study: 25345912

Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Patient group (recurrent epistaxis)
Number of subjects: 90
Study: 23438054

Group type: EXPERIMENTAL
Intervention: Collagen/ORC/silver therapy
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control treatment (standard treatment)
Number of subjects: 39
Study: 21493994

Group type: COMPARATOR
Intervention: Generic propofol (Group 1)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Generic propofol with lidocaine (Group 2)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Propofol lipuro (Group 3)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Propofol lipuro with lidocaine (Group 4)
Number of subjects: 120
Study: 19269139

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 110

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 110
Study: 16862356

Group type: EXPERIMENTAL
Intervention: Pendulum appliance
Number of subjects: 30

Group type: COMPARATOR
Intervention: Traditional face-bow
Number of subjects: 30
Study: 15547019

Group type: EXPERIMENTAL
Intervention: Echocardiography
Number of subjects: 86

Group type: COMPARATOR
Intervention: Radionuclide ventriculography
Number of subjects: 86
Study: 11360851

Group type: EXPERIMENTAL
Intervention: Glucose 5% infusion
Number of subjects: 53

Group type: COMPARATOR
Intervention: Xylose 5% infusion
Number of subjects: 53

Group type: COMPARATOR
Intervention: Electrolyte infusion
Number of subjects: 53
Study: 9428058

Group type: EXPERIMENTAL
Intervention: Electro-acupuncture (EA) treatment for 4 weeks
Number of subjects: 12
Study: 8098392

Group type: EXPERIMENTAL
Intervention: Rapid infusion of 125 mL of an aminoacid mixture (Synthamin 14 without electrolytes) over 5 min (2.1 g per min)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Rapid infusion of 50 mL of aminoacids over 5 min
Number of subjects: 8
Study: 3318991

Group type: EXPERIMENTAL
Intervention: Reality orientation followed by reminiscence therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reminiscence therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reality orientation
Number of subjects: 0
Study: 28460406

Group type: EXPERIMENTAL
Intervention: Burst TENS
Number of subjects: 53

Group type: COMPARATOR
Intervention: Sham burst TENS
Number of subjects: 53
Study: 27084667

Group type: EXPERIMENTAL
Intervention: CPG-based clinical decision support system (CDSS) for WSL prevention
Number of subjects: 840

Group type: COMPARATOR
Intervention: Usual preventive measures
Number of subjects: 840
Study: 24557441

Group type: EXPERIMENTAL
Intervention: EMLA(®) cream
Number of subjects: 200

Group type: COMPARATOR
Intervention: Traditional anesthetic technique (lidocaine 10% and 2%)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Both groups (EMLA(®) cream and traditional anesthetic)
Number of subjects: 200
Study: 24054359

Group type: EXPERIMENTAL
Intervention: Nasal ketorolac challenge
Number of subjects: 165
Study: 20390497

Group type: EXPERIMENTAL
Intervention: m-DOT (modified-directly observed therapy)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 94
Study: 17522928

Group type: EXPERIMENTAL
Intervention: Group 1: overnight infusion and a bolus of colloid before induction of anesthesia, followed by a bolus just before pneumoperitoneum (PP)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Group 2: overnight infusion and a colloid bolus before anesthesia
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group: received only infusion during operation
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 21
Study: 17201719

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Supportive Therapy (ST)
Number of subjects: 27
Study: 12364992

Group type: EXPERIMENTAL
Intervention: Endoscopic clipping (group I)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Endoscopic band ligation (group II)
Number of subjects: 40
Study: 10227461

Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy and autologous stem cell support
Number of subjects: 313

Group type: COMPARATOR
Intervention: Melphalan-prednisone (initial therapy)
Number of subjects: 313

Group type: COMPARATOR
Intervention: All patients with symptomatic myeloma
Number of subjects: 313
Study: 8572039

Group type: EXPERIMENTAL
Intervention: Estring (estradiol-releasing vaginal ring, 6.5 to 9.5 micrograms per 24 hours)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Estring (estradiol-releasing vaginal ring)
Number of subjects: 136
Study: 1882999

Group type: EXPERIMENTAL
Intervention: Desipramine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 6337618

Group type: EXPERIMENTAL
Intervention: Sulconazole 1% cream
Number of subjects: 40

Group type: COMPARATOR
Intervention: Clotrimazole 1% cream
Number of subjects: 40
Study: 30556374

Group type: EXPERIMENTAL
Intervention: Immediately loaded group (loaded on the same day as implant insertion)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Conventionally loaded group (loaded 3 months after implant insertion)
Number of subjects: 19
Study: 29019012

Group type: EXPERIMENTAL
Intervention: BOOST-A™ transition planning program
Number of subjects: 72
Study: 26762900

Group type: EXPERIMENTAL
Intervention: Direct Access (DA) system
Number of subjects: 311

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 311
Study: 24669841

Group type: EXPERIMENTAL
Intervention: Recombinant IFN‐γ (rIFN‐γ, 100 μg s.c., thrice a week) for 2 weeks
Number of subjects: 8

Group type: COMPARATOR
Intervention: Standard antifungal therapy
Number of subjects: 8
Study: 22982081

Group type: EXPERIMENTAL
Intervention: Problem-Solving Therapy (PST: in-person or telehealth delivery)
Number of subjects: 121
Study: 20455367

Group type: EXPERIMENTAL
Intervention: Clark Simulation Evaluation Rubric
Number of subjects: 178
Study: 18973065

Group type: EXPERIMENTAL
Intervention: Rivastigmine (1.5 mg once a day increment over 4 weeks to 3 mg twice daily)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: COMPARATOR
Intervention: Comparison between Rivastigmine and Placebo
Number of subjects: 60
Study: 16076046

Group type: EXPERIMENTAL
Intervention: Exogenous activated protein C (drotrecogine alpha) included in therapy for sepsis
Number of subjects: 0
Study: 12602460

Group type: EXPERIMENTAL
Intervention: Fosinopril 5-20 mg/day
Number of subjects: 397

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 397
Study: 9882083

Group type: EXPERIMENTAL
Intervention: dexketoprofen trometamol 25 mg
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: dexketoprofen trometamol 12.5 mg
Number of subjects: 125

Group type: COMPARATOR
Intervention: dipyrone 575 mg
Number of subjects: 125
Study: 7925220

Group type: EXPERIMENTAL
Intervention: 100 g boiled carrots
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 200 g boiled carrots
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 300 g boiled carrots
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 200 g boiled carrots with lactic acid
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control meal without vegetables
Number of subjects: 10
Study: 2635834

Group type: EXPERIMENTAL
Intervention: Subcutaneous immunotherapy (SI)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Oral immunotherapy (OI)
Number of subjects: 28
Study: 28675941

Group type: EXPERIMENTAL
Intervention: Schedules, Tools, and Activities for Transitions (STAT) program
Number of subjects: 150

Group type: COMPARATOR
Intervention: Waitlist (Control)
Number of subjects: 150
Study: 26621261

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Nortriptyline
Number of subjects: 136

Group type: COMPARATOR
Intervention: Both escitalopram and nortriptyline
Number of subjects: 136
Study: 24841105

Group type: EXPERIMENTAL
Intervention: Sodium pyruvate (0.1 g·kg(‐1) of body mass)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 21976386

Group type: EXPERIMENTAL
Intervention: Carboplatin-pegylated liposomal doxorubicin (CD)
Number of subjects: 344

Group type: COMPARATOR
Intervention: Carboplatin-paclitaxel (CP)
Number of subjects: 344
Study: 21135995

Group type: EXPERIMENTAL
Intervention: Fibrin glue for conjunctival autograft (Group 1)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sutures for conjunctival autograft (Group 2)
Number of subjects: 50
Study: 18082488

Group type: EXPERIMENTAL
Intervention: MRP-8/14 levels measured at 30 days after acute coronary syndrome
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: MRP-8/14 quartiles
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Elevated MRP-8/14 and high-sensitivity C-reactive protein
Number of subjects: 237
Study: 17081360

Group type: EXPERIMENTAL
Intervention: SCD group (n = 36)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group I (non-SCD CHD, n = 28)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group II (non-cardiac death, n = 26)
Number of subjects: 90
Study: 12843739

Group type: EXPERIMENTAL
Intervention: HIV‐1 p24 antigen test (signal amplification‐boosted ELISA of heat‐denatured plasma)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Batch-wise retesting of samples from patients
Number of subjects: 55
Study: 11395246

Group type: COMPARATOR
Intervention: Control (Arm A) - 15 Gy/5 fractions/5 days
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Hyperfractionation (Arm B) - 8 Gy/2 fractions/1 day
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Accelerated Hyperfractionation (Arm C) - 12 Gy/4 fractions/2 days
Number of subjects: 156
Study: 9219165

Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 7900267

Group type: EXPERIMENTAL
Intervention: Chronic NSAID use
Number of subjects: 140

Group type: COMPARATOR
Intervention: No NSAID use
Number of subjects: 140
Study: 3118755

Group type: EXPERIMENTAL
Intervention: Nitroglycerin discs (30 mg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 2294222

Group type: EXPERIMENTAL
Intervention: Low-fat diet intervention
Number of subjects: 73
Study: 1097196

Group type: EXPERIMENTAL
Intervention: Cephradine
Number of subjects: 42

Group type: COMPARATOR
Intervention: Ampicillin
Number of subjects: 42
Study: 31021842

Group type: EXPERIMENTAL
Intervention: Dorsoulnar incision
Number of subjects: 46

Group type: COMPARATOR
Intervention: Early mobilization
Number of subjects: 46

Group type: COMPARATOR
Intervention: Midline incision
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Dorsoulnar incision and immobilization
Number of subjects: 46
Study: 28711118

Group type: EXPERIMENTAL
Intervention: Mental imagery training (eight 10-minute sessions every second day via the Internet)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Wait condition (control group)
Number of subjects: 30
Study: 26362659

Group type: EXPERIMENTAL
Intervention: MMRV/MMRV
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MMR/MMRV
Number of subjects: 0

Group type: COMPARATOR
Intervention: MMR/MMR+V (control group)
Number of subjects: 0
Study: 24187865

Group type: EXPERIMENTAL
Intervention: Scraping therapy at acupoint until appearance of skin eruptions
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Scraping therapy along channel until appearance of skin eruptions
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Scraping therapy at acupoint without appearance of skin eruptions
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Scraping therapy along channel without appearance of skin eruptions
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 210
Study: 21894054

Group type: EXPERIMENTAL
Intervention: Vitamin D supplement 1,520 IU/daily
Number of subjects: 30

Group type: COMPARATOR
Intervention: Ultraviolet radiation B (UVB) 6 min weekly
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 19746407

Group type: EXPERIMENTAL
Intervention: Randomized Controlled Trials (RCT)
Number of subjects: 1627

Group type: EXPERIMENTAL
Intervention: Observational/Descriptive Studies
Number of subjects: 1627

Group type: EXPERIMENTAL
Intervention: Meta-Analyses
Number of subjects: 1627

Group type: EXPERIMENTAL
Intervention: Validation Studies
Number of subjects: 1627

Group type: EXPERIMENTAL
Intervention: Others
Number of subjects: 1627
Study: 17727941

Group type: COMPARATOR
Intervention: Stable BMI (+/‐0.5 kg/m(2))
Number of subjects: 13230

Group type: EXPERIMENTAL
Intervention: Increase in BMI >/=2.0 kg/m(2)
Number of subjects: 13230

Group type: EXPERIMENTAL
Intervention: Decrease in BMI
Number of subjects: 13230
Study: 15482031

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided thrombin injection
Number of subjects: 30

Group type: COMPARATOR
Intervention: Ultrasound-guided compression
Number of subjects: 30
Study: 11533565

Group type: EXPERIMENTAL
Intervention: Plyometric training (JG) 3 days/week for 10 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Reduced training period (8 weeks) for both groups
Number of subjects: 20
Study: 10204428

Group type: EXPERIMENTAL
Intervention: Light-cured resin-modified glass-ionomer adhesive (Fuji Ortho LC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Acid-etch chemically-cured composite (Orthodontic Concise)
Number of subjects: 0
Study: 8144726

Group type: EXPERIMENTAL
Intervention: Paramedic-initiated thrombolysis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hospital-initiated thrombolysis
Number of subjects: 0
Study: 3043370

Group type: EXPERIMENTAL
Intervention: Imipramine (low, medium, and high doses)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 31337437

Group type: EXPERIMENTAL
Intervention: Behaviour change intervention with classroom-based session (CBS) and SMS reminders to brush teeth twice daily
Number of subjects: 5040

Group type: COMPARATOR
Intervention: Usual curriculum and no SMS
Number of subjects: 5040
Study: 29455504

Group type: EXPERIMENTAL
Intervention: Voluntary rehabilitation exercise combined with isometric extension of quadriceps femoris
Number of subjects: 90

Group type: COMPARATOR
Intervention: Apparatus training combined with isometric extension of quadriceps femoris
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Both groups (experimental and control)
Number of subjects: 90
Study: 25923275

Group type: EXPERIMENTAL
Intervention: Nasal saline spray and a 3‐day course of antibiotics (either amoxicillin/clavulanate or levofloxacin)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Nasal saline alone
Number of subjects: 50
Study: 23864175

Group type: EXPERIMENTAL
Intervention: Semitendinosus and gracilis tendon group (STG)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Bone-patellar tendon-bone group (BPTB)
Number of subjects: 42

Group type: COMPARATOR
Intervention: ACL reconstruction groups (STG and BPTB)
Number of subjects: 42
Study: 21494053

Group type: EXPERIMENTAL
Intervention: Olanzapine (5 mg)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 18653753

Group type: EXPERIMENTAL
Intervention: High-carbohydrate (HC) diet (7 g.kg(‐1).day(‐1))
Number of subjects: 7

Group type: COMPARATOR
Intervention: Low-carbohydrate (LC) diet (2.9 g.kg(‐1).day(‐1))
Number of subjects: 7
Study: 16442046

Group type: EXPERIMENTAL
Intervention: 1,450 nm laser alone
Number of subjects: 20

Group type: COMPARATOR
Intervention: Microdermabrasion plus 1,450 nm laser
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 20